Today@Dal

The Canadian Center for Vaccinology is looking for participants between 24 to 36 weeks pregnant to receive a vaccine to protect both mom and baby against RSV.

What is the purpose of this study?

The MATISSE maternal vaccine study wants to find out if giving expecting mothers an investigational vaccine or respiratory syncytial virus (RSV) is safe and could help protect their babies from RSV after they are born.

Who is eligible?

You might qualify for this research if you are:

• Between 18 and 49-years-old
• Healthy and expecting a single healthy baby
• Between 24 to 36 weeks pregnant when you receive the study vaccine
• Not planning on having your baby at home
• Willing and able to attend study visits and follow instructions from your study team

You need to meet other requirements to participate and your study team will talk you through these requirements during a screening visit.

What am I required to do?

You will have four planned study visits over the course of about 10 months after you receive the vaccine. Your baby will have six planned study visits during the first 24 months of their life. Your baby may have extra study visits if they get sick. Some of these checks may be done over the phone.

If you are interested in participating in this study or would like to know more, please contact Angi Perreault at angela.perreault@iwk.nshealth.ca.

Please also visit our website for additional information: https://centerforvaccinology.ca/study/matisse/